| Followers | 53 |
| Posts | 14433 |
| Boards Moderated | 0 |
| Alias Born | 06/15/2014 |
Saturday, August 02, 2025 10:28:28 AM
Kiwi thanks for taking the time to write your thoughts on these two stocks. I imagine the p value in the pediatric study was positive even though the sample size was small. I did find some info about the FDA funding for it:
"SCD-PED-01 was funded primarily by an Office of Orphan Products Development (OOPD) grant (R01FD005092) from the US FDA with a small subsequent grant from SeaStar Medical Inc to complete the final 2 participants’ enrollment. SCD-PED-02 was funded by the Frankel Innovation Initiative at the University of Michigan. None of the aforementioned sponsors had any role in study design, collection, analysis, and interpretation of data, writing the report, or the decision to submit the report for publication"https://www.sciencedirect.com/science/article/pii/S2590059524000037
Also, it must not be terribly easy to enroll patients who are on their deathbed. Or maybe it is, not sure how that situation is handled.
"SCD-PED-01 was funded primarily by an Office of Orphan Products Development (OOPD) grant (R01FD005092) from the US FDA with a small subsequent grant from SeaStar Medical Inc to complete the final 2 participants’ enrollment. SCD-PED-02 was funded by the Frankel Innovation Initiative at the University of Michigan. None of the aforementioned sponsors had any role in study design, collection, analysis, and interpretation of data, writing the report, or the decision to submit the report for publication"https://www.sciencedirect.com/science/article/pii/S2590059524000037
Also, it must not be terribly easy to enroll patients who are on their deathbed. Or maybe it is, not sure how that situation is handled.
Recent UNCY News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2026 08:30:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2026 08:30:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2026 08:30:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 11:51:50 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2026 10:30:46 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/30/2026 11:04:02 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/30/2026 11:02:10 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/30/2026 11:00:08 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/06/2026 01:11:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 11:29:20 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 10:32:02 AM
- Unicycive shares gain as FDA accepts resubmitted OLC NDA • IH Market News • 01/29/2026 03:01:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:14 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/14/2025 10:09:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 02:12:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:39:29 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/28/2025 11:30:13 AM
- UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit • PR Newswire (US) • 10/14/2025 06:55:00 AM
